| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |